← Browse by Condition
Medical Condition
vaccine
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 4
NCT06799013 Phase 1
Recruiting
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
Enrollment
48 pts
Location
United States
Sponsor
HDT Bio
NCT04460235 Phase 4
Recruiting
Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma
Enrollment
160 pts
Location
France
Sponsor
Poitiers University Hospital